RxDoctor Payments Data

Richard Delvalle, MD

Internal Medicine · Taylorville, ILNPI 1932290384

Payments from drug & device makers

$354in general payments, 2019–2025

Across 24 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$74
  • Amgen$67
  • Novo Nordisk$36
  • Pfizer$30
  • Lilly USA, LLC$28
  • AbbVie$23
  • plus $95 from 7 others

What the payments were for

  • Food & beverage$33193%
  • Education$237%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$354 in reported general payments places this provider in the 60th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$231,061
Medicare patients
506
Services billed
7,659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban338$270,976
OzempicSemaglutide152$163,209
MounjaroTirzepatide90$85,359
JardianceEmpagliflozin79$84,195
XareltoRivaroxaban68$56,645
TrulicityDulaglutide44$53,294
Repatha SyringeEvolocumab54$47,477
RybelsusSemaglutide26$36,164
EntrestoSacubitril/Valsartan21$19,781
Repatha SureclickEvolocumab16$19,395
Breo ElliptaFluticasone/Vilanterol38$16,795
LinzessLinaclotide29$16,727
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$16,242
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm109$15,641
Spiriva RespimatTiotropium Bromide16$13,455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$270,976338 claims
Novo NordiskOzempic, Rybelsus$36$199,373178 claims
Lilly USA, LLCMounjaro, Trulicity$28$138,653134 claims
Johnson & JohnsonXarelto$13$56,64568 claims
NovartisEntresto$14$19,78121 claims
AbbVieLinzess$23$16,72729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Taylorville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →